The long view on living with COVID-19 as an endemic disease calls for expanding the
planetary health intervention toolbox. We will need a battery of vaccines, small molecule oral …

Meaningful metrics of antiviral activity are essential for determining the efficacy of
therapeutics in human clinical trials. Molnupiravir (MOV) is a broadly acting antiviral …

The COVID-19 pandemic needs no introduction at present. Only a few treatments are
available for this disease, including remdesivir and favipiravir. Accordingly, the …

Coronavirus disease 2019 (COVID-19) is a systemic disease that impacts multiple organ
systems with a complex clinical presentation and outcomes that can vary from person to …

Despite the progress in the management of COVID-19, effective oral antiviral agents are still
lacking. In the present review, the potential beneficial effects of molnupiravir in the …

COVID-19 medicines, such as molnupiravir are beginning to emerge for public health and
clinical practice. On the other hand, drugs display marked variability in their efficacy and …

The global COVID-19 pandemic is currently underway. To date, there are approximately
4.55 million deaths and 219 million people infected [1]. The massive vaccination campaign …

Background The study was aimed at encapsulating the evidence of in vitro and in vivo
antiviral activities of molnupiravir and its active form against highly pathogenic SARS-CoV-2 …

At a crucial time with rapid spread of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Omicron variant globally, the United States Food and Drug Administration …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has radically altered daily life. Effective antiviral …